- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.04. | NSE - Sientra, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 08.04. | Delisting of Securities of NanoString Technologies, Inc.; Remark Holdings, Inc.; Sunworks, Inc.; Cyanotech Corporation; Sientra, Inc.; Charge Enterprises, Inc. and others from The Nasdaq Stock Market | 138 | GlobeNewswire (Europe) | NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of NanoString Technologies, Inc. NanoString Technologies, Inc.'s securities... ► Artikel lesen | |
| 03.04. | Sientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction | 132 | GlobeNewswire (Europe) | Tiger Aesthetics Medical, LLC is the successful bidder for certain assets used in Sientra's breast reconstruction and augmentation business Nuance Intermediary, LLC is the successful bidder for substantially... ► Artikel lesen | |
| 29.03. | Sientra, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 01.03. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 01.03.2024 | 756 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 01.03.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 01.03.2024.ISIN NameCA29383X1033 ENTHEON... ► Artikel lesen | |
| 14.02. | Implant Maker Sientra Cleared to Draw Deerfield Bankruptcy Loan | 29 | BNN Bloomberg | ||
| 13.02. | Sientra Files For Bankruptcy; Stock Tanks 65% | 8 | RTTNews | ||
| 13.02. | Breast-Implant Maker Sientra Files Bankruptcy After Consumer Pullback | 7 | BNN Bloomberg | ||
| 13.02. | Sientra seeks buyer during Chapter 11 proceedings | 7 | Investing.com | ||
| 13.02. | Sientra, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 13.02. | Sientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process | 466 | GlobeNewswire (Europe) | IRVINE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) ("Sientra" or the "Company"), a surgical aesthetics company developing and commercializing safe and innovative solutions... ► Artikel lesen | |
| 29.01. | Sientra, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.01. | Sientra, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.12.23 | Sientra, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 13.11.23 | Sientra, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 10.11.23 | Earnings call: Sientra reports challenging Q3 2023 results, expresses optimism for recovery | 6 | Investing.com | ||
| 09.11.23 | Sientra Inc reports results for the quarter ended in September - Earnings Summary | 3 | Reuters | ||
| 09.11.23 | Recap: Sientra Q3 Earnings | 1 | Benzinga.com | ||
| 09.11.23 | Sientra GAAP EPS of -$1.31, revenue of $19.5M | 1 | Seeking Alpha | ||
| 09.11.23 | Sientra, Inc.: Sientra Reports Third Quarter Financial and Operational Results | 193 | GlobeNewswire (Europe) | IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) ("Sientra" or the "Company"), a surgical aesthetics company developing the safest and most innovative solutions for the... ► Artikel lesen |
Seite:
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 12,418 | -2,59 % | Teladoc Health, Inc.: Teladoc Health Provides Updated Start Time for First Quarter 2024 Earnings Call on April 25 | ||
| UNITEDHEALTH | 442,75 | +5,61 % | UnitedHealth Aktie: Wachstumsprognosen Trotz Aktienrückgang | UnitedHealth, der größte Krankenversicherer der USA, hat im letzten Handelsschluss einen leichten Anstieg von 0,06% verzeichnet und schloss bei 456 Dollar. Trotz der geringen Veränderung hat die Aktie... ► Artikel lesen | |
| THERMO FISHER | 522,30 | -0,48 % | Thermo Fisher Scientific Innovations at Analytica 2024 Optimize Workflows and Enable Precise Analysis Across Life Sciences, Applied and Industrial Markets | Educational sessions explore solving analytical challenges with innovative products Analytica 2024 -Thermo Fisher Scientific, Inc. is debuting its recently launched innovative products, hosting... ► Artikel lesen | |
| BIOTEST | 28,800 | 0,00 % | EQS-HV: Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 07.05.2024 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: Biotest Aktiengesellschaft
/ Bekanntmachung der Einberufung zur Hauptversammlung
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 07.05.2024... ► Artikel lesen | |
| ROKU | 54,36 | -2,00 % | Start auf Roku: ARTE baut Präsenz auf wichtigsten digitalen Plattformen und Ausspielwegen aus | Strasbourg (ots) - Mit dem Start auf der TV-Streaming-Plattform Roku Mitte April 2024 erweitert ARTE seine umfassende Präsenz auf digitalen Plattformen und Ausspielwegen. Durch diese neue Partnerschaft... ► Artikel lesen | |
| RESMED | 174,60 | +0,26 % | Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years | ||
| ATOSSA THERAPEUTICS | 1,452 | -10,04 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen | SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced promising safety and efficacy data from the Company's Phase 2 EVANGELINE... ► Artikel lesen | |
| HENRY SCHEIN | 67,22 | +0,99 % | Henry Schein appoints three new executives to leadership team | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 0,182 | +16,41 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States | BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| ZIMMER BIOMET | 117,00 | +0,26 % | Dividendenbekanntmachungen (27.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIA REALTY TRUST US0042391096 0,18 USD 0,1661 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,197 EUR ACME UNITED CORPORATION US0048161048 0... ► Artikel lesen | |
| PETMED EXPRESS | 3,916 | +1,11 % | PetMed Express, Inc.: PetMeds Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement | Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and PetPlus Membership, 52% of total revenue, up from 42% at the same time... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,249 | -2,73 % | Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG | RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) ("Asensus" or the "Company"), a medical device company that is digitizing the interface... ► Artikel lesen | |
| TANDEM DIABETES | 30,000 | +0,10 % | Tandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance | SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended... ► Artikel lesen | |
| QUIDELORTHO | 37,800 | -3,08 % | QuidelOrtho's (QDEL) New Test to Offer Enhanced Opioid Testing |
SIENTRA INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,054 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
